Trinity Biotech plc

Contributing Author

Recent Articles by Trinity Biotech plc

Dec-23	Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives TRIB GlobeNewswire
Dec-23	Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests TRIB GlobeNewswire
Dec-15	Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances TRIB GlobeNewswire
Nov-18	Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation TRIB GlobeNewswire
Nov-14	Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test TRIB GlobeNewswire
Oct-27	Trinity Biotech Welcomes Perceptive Advisor's Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth TRIB GlobeNewswire
Sep-02	Trinity Biotech Regains Compliance with Nasdaq Listing Requirements TRIB GlobeNewswire
Aug-21	Trinity Biotech Appoints Paul Tivnan as Non-Executive Director TRIB GlobeNewswire
Aug-20	Regulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation TRIB GlobeNewswire
Aug-14	Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara Preeclampsia Testing Service TRIB GlobeNewswire
Aug-12	Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor TRIB GlobeNewswire
Aug-07	Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service TRIB GlobeNewswire
Jul-24	Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market TRIB GlobeNewswire
Jul-01	Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround TRIB GlobeNewswire
Jun-24	Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation TRIB GlobeNewswire
May-15	Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update TRIB GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.